Expanded Access Treatment Protocol: Remdesivir (RDV; GS-5734) for the Treatment of SARS-CoV2 (CoV) Infection

Brief description of study

The purpose of this research study is to see whether remdesivir (RDV) works against SARS-2-CoV. This treatment uses an investigational drug named remdesivir (GS-5734). Investigational means that the Food and Drug Administration (FDA) has not yet approved the drug for this use. How well this investigational drug works or even if it is safe has not yet been proven through clinical trials.


Clinical Study Identifier: s20-00549
ClinicalTrials.gov Identifier: NCTs20-00549


If you are registered as a volunteer, please login to the dashboard to send referrals.